Remove FDA Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

First UK-licensed melatonin for children with insomnia and ADHD

European Pharmaceutical Review

AGB-Pharma , the Swedish pharmaceutical company that produced the drug, predicted around 60 percent of all melatonin prescriptions are dispensed to under 18s off-label or unlicensed. Melatonin is commonly used to treat insomnia. Adaflex is available in a range of doses (1mg, 2mg, 3mg, 4mg and 5mg), unlike other melatonin products.

article thumbnail

Regulatory, Compliance and Quality Challenges, Learnings, and Future Opportunities

ISPE

Advanced therapies within combination products represent a frontier where pharmaceutical innovation meets medical technology. This fusion has the potential to revolutionize patient care, offering novel solutions that were once beyond reach. Special Highlight: Keynote Session with FDA's Commissioner Robert M.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Why is Patient Engagement Important for Pharma? Prioritize customer support Customer support has emerged as a critical factor in patient engagement.

article thumbnail

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

Over the past five years, medical XR companies that were smaller start-ups have evolved into multimillion-dollar enterprises, partnering with pharmaceutical companies to supply digital therapeutic solutions using 3D immersive technology.

article thumbnail

12 Medications With Off-Label Uses

BuzzRx

Food and Drug Administration (FDA) has to undergo several rigorous phases before approving new medications. Once the FDA approves a new drug, it means that when using this drug for an approved condition, the potential benefits outweigh the potential risks. Given to a patient population for which they do not have FDA approval.

article thumbnail

Complete guide on pharmaceutical medical affairs

Viseven

There are also additional responsibilities of these teams, which include : Conducting non-registered clinical trials after the FDA approval of a drug. The role of medical affairs in pharmaceutical companies. The medical affairs team’s contribution has a far-reaching impact on patient care.

article thumbnail

What is RWE in Pharma?

Viseven

Food and Drug Administration ( FDA ) characterizes RWE as “the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from real-world data analysis.” Use of Real-World Evidence in Pharmaceutical Companies. public health data from various government data sources.